Browse by UCL people
Group by: Type | Date
Number of items: 34.
2025
Rupasinghe, Dhanushi;
Bansi-Matharu, Loveleen;
Law, Matthew;
Zangerle, Robert;
Rauch, Andri;
Tarr, Philip E;
Greenberg, Lauren;
... Petoumenos, Kathy; + view all
(2025)
Integrase Strand Transfer Inhibitor–Related Changes in Body Mass Index and Risk of Diabetes: A Prospective Study From the RESPOND Cohort Consortium.
Clinical Infectious Diseases
, 80
(2)
pp. 404-416.
10.1093/cid/ciae406.
|
2024
|
Byonanebye, DM;
Polizzotto, MN;
Maltez, F;
Rauch, A;
Grabmeier-Pfistershammer, K;
Wit, F;
De Wit, S;
... Petoumenos, K; + view all
(2024)
Associations between change in BMI and the risk of hypertension and dyslipidaemia in people receiving integrase strand-transfer inhibitors, tenofovir alafenamide, or both compared with other contemporary antiretroviral regimens: a multicentre, prospective observational study from the RESPOND consortium cohorts.
The Lancet HIV
, 11
(5)
e321-e332.
10.1016/S2352-3018(23)00328-4.
|
2023
|
Smith, Jennifer;
Bansi-Matharu, Loveleen;
Cambiano, Valentina;
Dimitrov, Dobromir;
Bershteyn, Anna;
van de Vijver, David;
Kripke, Katharine;
... HIV Modelling Consortium; + view all
(2023)
Predicted effects of the introduction of long-acting injectable cabotegravir pre-exposure prophylaxis in sub-Saharan Africa: a modelling study.
The Lancet HIV
10.1016/S2352-3018(22)00365-4.
(In press).
|
2022
|
Bansi-Matharu, Loveleen;
Mudimu, Edinah;
Martin-Hughes, Rowan;
Hamilton, Matt;
Johnson, Leigh;
Ten Brink, Debra;
Stover, John;
... Bershteyn, Anna; + view all
(2022)
Cost-effectiveness of voluntary medical male circumcision for HIV prevention across sub-Saharan Africa: results from five independent models.
The Lancet Global Health
10.1016/S2214-109X(22)00515-0.
(In press).
|
|
Bershteyn, Anna;
Jamieson, Lise;
Kim, Hae-Young;
Platais, Ingrida;
Milali, Masabho P;
Mudimu, Edinah;
Ten Brink, Debra;
... Nichols, Brooke E; + view all
(2022)
Transmission reduction, health benefits, and upper-bound costs of interventions to improve retention on antiretroviral therapy: a combined analysis of three mathematical models.
Lancet Glob Health
, 10
(9)
e1298-e1306.
10.1016/S2214-109X(22)00310-2.
|
 |
|
Greenberg, Lauren;
Ryom, Lene;
Neesgaard, Bastian;
Miró, Jose M;
Dahlerup Rasmussen, Line;
Zangerle, Robert;
Grabmeier-Pfistershammer, Katharina;
... RESPOND Study Group, .; + view all
(2022)
Integrase Strand Transfer Inhibitor Use and Cancer Incidence in a Large Cohort Setting.
Open Forum Infectious Diseases
, 9
(3)
, Article ofac029. 10.1093/ofid/ofac029.
|
|
|
Jaschinski, Nadine;
Greenberg, Lauren;
Neesgaard, Bastian;
Miró, Jose M;
Grabmeier-Pfistershammer, Katharina;
Wandeler, Gilles;
Smith, Colette;
... RESPOND Study Group, .; + view all
(2022)
Recent abacavir use and incident cardiovascular disease in contemporary treated people living with HIV.
AIDS
10.1097/QAD.0000000000003373.
(In press).
|
|
Neesgaard, Bastian;
Greenberg, Lauren;
Miró, Jose M;
Grabmeier-Pfistershammer, Katharina;
Wandeler, Gilles;
Smith, Colette;
De Wit, Stéphane;
... Ryom, Lene; + view all
(2022)
Associations between integrase strand-transfer inhibitors and cardiovascular disease in people living with HIV: a multicentre prospective study from the RESPOND cohort consortium.
The Lancet HIV
, 9
(7)
e474-e485.
10.1016/S2352-3018(22)00094-7.
|
|
Phillips, Andrew N;
Bershteyn, Anna;
Revill, Paul;
Bansi-Matharu, Loveleen;
Kripke, Katharine;
Boily, Marie-Claude;
Martin-Hughes, Rowan;
... HIV Modelling Consortium; + view all
(2022)
Cost-effectiveness of easy-access, risk-informed oral pre-exposure prophylaxis in HIV epidemics in sub-Saharan Africa: a modelling study.
Lancet HIV
, 9
(5)
e353-e362.
10.1016/S2352-3018(22)00029-7.
|
|
Revill, P;
Rangaraj, A;
Makochekanwa, A;
Mpofu, A;
Ciaranello, AL;
Jahn, A;
Gonani, A;
... Cambiano, V; + view all
(2022)
Perspectives on the use of modelling and economic analysis to guide HIV programmes in sub-Saharan Africa.
The Lancet HIV
, 9
(7)
e517-e520.
10.1016/S2352-3018(22)00035-2.
|
2021
|
Bansi-Matharu, L;
Phillips, A;
Oprea, C;
Grabmeier-Pfistershammer, K;
Günthard, HF;
De Wit, S;
Guaraldi, G;
... Ryom, L; + view all
(2021)
Contemporary antiretrovirals and body-mass index: a prospective study of the RESPOND cohort consortium.
The Lancet HIV
, 8
(11)
e711-e722.
10.1016/S2352-3018(21)00163-6.
|
|
Greenberg, L;
Ryom, L;
Neesgaard, B;
Wandeler, G;
Staub, T;
Gisinger, M;
Skoll, M;
... RESPOND study group; + view all
(2021)
Clinical Outcomes of 2-Drug Regimens vs 3-Drug Regimens in Antiretroviral Treatment–Experienced People Living With Human Immunodeficiency Virus.
Clinical Infectious Diseases
, 73
(7)
e2323-e2333.
10.1093/cid/ciaa1878.
|
|
Phillips, AN;
Bansi-Matharu, L;
Cambiano, V;
Ehrenkranz, P;
Serenata, C;
Venter, F;
Pett, S;
... Garnett, GP; + view all
(2021)
The potential role of long-acting injectable cabotegravir-rilpivirine in the treatment of HIV in sub-Saharan Africa: a modelling analysis.
The Lancet Global Health
10.1016/S2214-109X(21)00025-5.
(In press).
|
|
2020
|
Jewell, BL;
Mudimu, E;
Stover, J;
ten Brink, D;
Phillips, AN;
Smith, JA;
Martin-Hughes, R;
... HIV Modelling Consortium; + view all
(2020)
Potential effects of disruption to HIV programmes in sub-Saharan Africa caused by COVID-19: results from multiple mathematical models.
The Lancet HIV
10.1016/S2352-3018(20)30211-3.
(In press).
|
|
|
Phillips, AN;
Bansi-Matharu, L;
Venter, F;
Havlir, D;
Pozniak, A;
Kuritzkes, DR;
Wensing, A;
... Bertagnolio, S; + view all
(2020)
Updated assessment of risks and benefits of dolutegravir versus efavirenz in new antiretroviral treatment initiators in sub-Saharan Africa: modelling to inform treatment guidelines.
Lancet HIV
10.1016/S2352-3018(19)30400-X.
|
|
|
Shroufi, A;
Van Cutsem, G;
Cambiano, V;
Bansi-Matharu, L;
Duncan, K;
Murphy, RA;
Maman, D;
(2020)
HIV viral load algorithm: what are the needs in the field?: authors' response.
AIDS
, 34
(1)
pp. 160-162.
10.1097/QAD.0000000000002383.
|
2019
|
Bansi-Matharu, L;
Loria, GR;
Cole, SR;
Mugerwa, H;
Vecino, I;
Lundgren, J;
Pulik, P;
... INSIGHT START Study Group; + view all
(2019)
Risk factors for antiretroviral therapy (ART) discontinuation in a large multinational trial of early ART initiators.
AIDS
, 33
(8)
pp. 1385-1390.
10.1097/QAD.0000000000002210.
|
|
Cowan, FM;
Chabata, ST;
Musemburi, S;
Fearon, E;
Davey, C;
Ndori-Mharadze, T;
Bansi-Matharu, L;
... Phillips, AN; + view all
(2019)
Strengthening the scale-up and uptake of effective interventions for sex workers for population impact in Zimbabwe.
Journal of the International AIDS Society
, 22
(S4)
, Article e25320. 10.1002/jia2.25320.
|
|
|
Geary, RS;
Gurol-Urganci, I;
Kiran, A;
Cromwell, DA;
Bansi-Matharu, L;
Shakespeare, J;
Mahmood, T;
(2019)
Factors associated with receiving surgical treatment for menorrhagia in England and Wales: findings from a cohort study of the National Heavy Menstrual Bleeding Audit.
BMJ Open
, 9
(2)
, Article e024260. 10.1136/bmjopen-2018-024260.
|
|
|
Phillips, A;
Cambiano, V;
Johnson, L;
Nakagawa, F;
Homan, R;
Meyer-Rath, G;
Rehle, T;
... Revill, P; + view all
(2019)
Potential impact and cost-effectiveness of condomless-sex-concentrated PrEP in KwaZulu-Natal accounting for drug resistance.
The Journal of Infectious Diseases
10.1093/infdis/jiz667.
(In press).
|
|
|
Phillips, A;
Cambiano, V;
Nakagawa, F;
Bansi-Matharu, L;
Wilson, D;
Jani, I;
Apollo, T;
... Revill, P; + view all
(2019)
Cost-per-diagnosis as a metric for monitoring cost effectiveness of HIV testing programmes in low income settings in southern Africa: health economic and modelling analysis.
The Journal of the International AIDS Society (JIAS)
, 22
(7)
, Article e25325. 10.1002/jia2.25325.
|
|
|
Phillips, AN;
Venter, F;
Havlir, D;
Pozniak, A;
Kuritzkes, D;
Wensing, A;
Lundgren, JD;
... Calmy, A; + view all
(2019)
Risks and benefits of dolutegravir-based antiretroviral drug regimens in sub-Saharan Africa: a modelling study.
The Lancet HIV
, 6
(2)
e116-e127.
10.1016/S2352-3018(18)30317-5.
|
|
|
Shroufi, A;
Van Cutsem, G;
Cambiano, V;
Bansi-Matharu, L;
Duncan, K;
Murphy, RA;
Mamana, D;
(2019)
Simplifying switch to second-line antiretroviral therapy in sub Saharan Africa: predicted effect of using a single viral load to define efavirenz-based first-line failure.
AIDS
, 33
(10)
pp. 1635-1644.
10.1097/QAD.0000000000002234.
|
|
2018
|
Bansi-Matharu, L;
Cambiano, V;
Apollo, T;
Yekeye, R;
Dirawo, J;
Musemburi, S;
Davey, C;
... Phillips, AN; + view all
(2018)
90‐90‐90 by 2020? Estimation and projection of the adult HIV epidemic and ART programme in Zimbabwe – 2017 to 2020.
Journal of the International AIDS Society
, 21
(11)
, Article e25205. 10.1002/jia2.25205.
|
|
Kiran, A;
Geary, RS;
Gurol-Urganci, I;
Cromwell, DA;
Bansi-Matharu, L;
Shakespeare, J;
Mahmood, T;
(2018)
Sociodemographic differences in symptom severity and duration among women referred to secondary care for menorrhagia in England and Wales: a cohort study from the National Heavy Menstrual Bleeding Audit.
BMJ Open
, 8
(2)
, Article e018444. 10.1136/bmjopen-2017-018444.
|
|
2017
|
Barber, TJ;
Bansi, L;
Pozniak, A;
Asboe, D;
Nelson, M;
Moyle, G;
Davies, N;
... Gazzard, B; + view all
(2017)
Low levels of neurocognitive impairment detected in screening HIV-infected men who have sex with men: The MSM Neurocog Study.
International Journal of STD & AIDS
, 28
(7)
pp. 715-722.
10.1177/0956462416665061.
|
|
2016
|
Phillips, AN;
Cambiano, V;
Nakagawa, F;
Bansi-Matharu, L;
Sow, PS;
Ehrenkranz, P;
Ford, D;
... Revill, P; + view all
(2016)
Cost Effectiveness of Potential ART Adherence Monitoring Interventions in Sub-Saharan Africa.
PLOS ONE
, 11
(12)
, Article e0167654. 10.1371/journal.pone.0167654.
|
|
|
Phillips, AN;
Cambiano, V;
Nakagawa, F;
Ford, D;
Apollo, T;
Murungu, J;
Rousseau, C;
... Revill, P; + view all
(2016)
Point-of-Care Viral Load Testing for Sub-Saharan Africa: Informing a Target Product Profile.
Open Forum Infectious Diseases
, 3
(3)
, Article ofw161. 10.1093/ofid/ofw161.
|
|
Phillips, AN;
Cambiano, V;
Revill, P;
Nakagawa, F;
Lundgren, JD;
Bansi-Matharu, L;
Mabugu, T;
... Hallett, TB; + view all
(2016)
Identifying Key Drivers of the Impact of an HIV Cure Intervention in Sub-Saharan Africa.
The Journal of Infectious Diseases
, 214
(1)
pp. 73-79.
10.1093/infdis/jiw120.
|
 |
2015
|
Phillips, A;
Shroufi, A;
Vojnov, L;
Cohn, J;
Roberts, T;
Ellman, T;
Bonner, K;
... Revill, P; + view all
(2015)
Sustainable HIV treatment in Africa through viral-load-informed differentiated care.
Nature
, 528
S68-S76.
10.1038/nature16046.
|
|
2013
|
Santoro, MM;
Sabin, C;
Forbici, F;
Bansi, L;
Dunn, D;
Fearnhill, E;
Boumis, E;
... Mussini, C; + view all
(2013)
Drug-resistance development differs between HIV-1-infected patients failing first-line antiretroviral therapy containing nonnucleoside reverse transcriptase inhibitors with and without thymidine analogues.
HIV Med
, 14
(9)
571 - 577.
10.1111/hiv.12044.
|
 |
2012
|
Price, H;
Bansi, L;
Sabin, CA;
Bhagani, S;
Burroughs, A;
Chadwick, D;
Dunn, D;
... UK Collaborative HIV Cohort Hepatitis Group, Steering Committee; + view all
(2012)
Hepatitis B virus infection in HIV-positive individuals in the UK collaborative HIV cohort (UK CHIC) study.
PLOS One
, 7
(11)
, Article e49314. 10.1371/journal.pone.0049314.
|
|
2011
|
Bansi, L.K.;
(2011)
Treatment strategies in HIV.
Doctoral thesis , UCL (University College London).
|
|
|
Huntington, SE;
Bansi, LK;
Thorne, C;
Anderson, J;
Newell, ML;
Taylor, GP;
Pillay, D;
... National Study of HIV in Pregnancy and Childhood; + view all
(2011)
Treatment switches during pregnancy among HIV-positive women on antiretroviral therapy at conception.
AIDS
, 25
(13)
1647 - 1655.
10.1097/QAD.0b013e32834982af.
|
|
